iShares Biotechnology ETF

IBBNASDAQ · USD
213.63USD+3.64 (+1.74%)

iShares Biotechnology ETF (IBB) Implied Volatility Current

IBB's 30 day implied volatility is 30.00%, with an IV Rank of 97.62%. This is a high IV Rank versus the past year, meaning iShares Biotechnology ETF options are relatively expensive and currently favor sellers. IBB's 30 day historical volatility sits at 29.41%, which means implied volatility is running roughly in line with historical volatility, as of Nov 5, 2026.

Read more

Tracking IBB implied volatility helps you spot when iShares Biotechnology ETF options are historically cheap or expensive, and where the best trades are hiding. When IBB IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor IBB implied volatility current levels in real time and filter for high probability trades.

Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking IBB IV rank helps you see whether IBB's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.

The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.

Implied Volatility

IV Rank
97.62%IV Rank
High

IV is highly elevated. Premiums are expensive, strongly favoring sellers.

Implied Volatility (30d)30.00%

IV Rank97.62%

Historical Volatility (30d)29.41%

IV Minus HV+0.59%

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →